Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease

Biochemical and Biophysical Research Communications

Volumn 430, Issue 3, 2013, Pages 907-911

  Kobayashi, Nobuyuki ^a   Nagata, Tomoyuki ^a   Shinagawa, Shunichiro ^a   Oka, Naomi ^a   Shimada, Kazuya ^a   Shimizu, Akihiro ^a   Tatebayashi, Yoshitaka ^b   Yamada, Hisashi ^a   Nakayama, Kazuhiko ^a   Kondo, Kazuhiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Alzheimer's disease; AMCI; Avidity index; Cognitive function; Herpes simplex virus type 1; Viral reactivation

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; IMMUNOGLOBULIN G ANTIBODY;

AGED; ALZHEIMER DISEASE; ANTIBODY TITER; ARTICLE; AVIDITY INDEX; BRAIN FUNCTION; CLINICAL ASSESSMENT TOOL; COGNITION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FRONTAL ASSESSMENT BATTERY; HERPES SIMPLEX VIRUS 1; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; VIRUS REACTIVATION;

AGED; ALZHEIMER DISEASE; AMNESIA; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; BRAIN-DERIVED NEUROTROPHIC FACTOR; EARLY DIAGNOSIS; FEMALE; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 1;

EID: 84872486944     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.054     Document Type: Article

References (32)

1. Baudic S., Barba G.D., Thibaudet M.C., Smagghe A., Remy P., Traykov L. Executive function deficits in early Alzheimer's disease and their relations with episodic memory. Arch. Clin. Neuropsychol. 2006, 21:15-21.
2. Perry R.J., Watson P., Hodges J.R. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia 2000, 38:252-271.
3. Itzhaki R.F., Lin W.R., Shang D., Wilcock G.K., Faragher B., Jamieson G.A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997, 349:241-244.
4. Wozniak M.A., Mee A.P., Itzhaki R.F. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J. Pathol. 2009, 217:131-138.
5. Pyles R.B. The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors. Herpes 2001, 8:64-68.
6. Wozniak M.A., Shipley S.J., Combrinck M., Wilcock G.K., Itzhaki R.F. Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J. Med. Virol. 2005, 75:300-306.
7. Whitley R., Kimberlin D.W., Prober C.G. Pathogenesis and disease. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis 2007, Cambridge. A. Arvin, G. Campadelli-Fiume, E. Mocarski, P.S. Moore, B. Roizman, R. Whitley, K. Yamanishi (Eds.).
8. Schillinger J.A., Xu F., Sternberg M.R., Armstrong G.L., Lee F.K., Nahmias A.J., McQuillan G.M., Louis M.E., Markowitz L.E. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex. Transm. Dis. 2004, 31:753-760.
9. Cheng S.B., Ferland P., Webster P., Bearer E.L. Herpes simplex virus dances with amyloid precursor protein while exiting the cell. PLoS One 2011, 6:e17966.
10. Feart C., Helmer C., Fleury H., Bejot Y., Ritchie K., Amouyel P., Schraen-Maschke S., Buee L., Lambert J.C., Letenneur L., Dartigues J.F. Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. PLoS One 2011, 6:e29480.
11. Itzhaki R. Herpes simplex virus type 1, apolipoprotein E and Alzheimer' disease. Herpes 2004, 11(Suppl. 2):77A-82A.
12. Renvoize E.B., Awad I.O., Hambling M.H. A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. Age Ageing 1987, 16:311-314.
13. Ounanian A., Guilbert B., Renversez J.C., Seigneurin J.M., Avrameas S. Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer's disease. J. Clin. Lab. Anal. 1990, 4:367-375.
14. Letenneur L., Peres K., Fleury H., Garrigue I., Barberger-Gateau P., Helmer C., Orgogozo J.M., Gauthier S., Dartigues J.F. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One 2008, 3:e3637.
15. Hashido M., Inouye S., Kawana T. Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay. J. Clin. Microbiol. 1997, 35:1766-1768.
16. Odievre M.H., Cointe D., Thebaud B., Zupan V., Ingrand D., Lacaze-Masmonteil T., Grangeot-Keros L. The assessment of IgG avidity in the evaluation of perinatal herpes simplex virus infection. J. Perinatol. 2002, 22:669-671.
17. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 2001, 58:1985-1992.
18. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
19. Kidd P.M. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern. Med. Rev. 2008, 13:85-115.
20. Sellner J., Lenhard T., Haas J., Einsiedel R., Meyding-Lamade U. Differential mRNA expression of neurotrophic factors GDNF, BDNF, and NT-3 in experimental herpes simplex virus encephalitis. Brain Res. Mol. Brain Res. 2005, 137:267-271.
21. Morichi S., Kashiwagi Y., Takekuma K., Hoshika A., Kawashima H. Expressions of brain-derived neurotrophic factor (BDNF) in cerebrospinal fluid and plasma of children with meningitis and encephalitis/encephalopathy. Int. J. Neurosci. 2013, 123:17-23.
22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
23. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
24. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000, 55:1621-1626.
25. Takagi R., Kajimoto Y., Kamiyoshi S., Miwa H., Kondo T. The frontal assessment battery at bed side (FAB) in patients with Parkinson's disease. No To Shinkei 2002, 54:897-902.
26. Hebert L.E., Scherr P.A., Beckett L.A., Albert M.S., Pilgrim D.M., Chown M.J., Funkenstein H.H., Evans D.A. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995, 273:1354-1359.
27. Kukull W.A., Higdon R., Bowen J.D., McCormick W.C., Teri L., Schellenberg G.D., van Belle G., Jolley L., Larson E.B. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch. Neurol. 2002, 59:1737-1746.
28. Raskind M.A. The clinical interface of depression and dementia. J. Clin. Psychiatry 1998, 59(Suppl. 10):9-12.
29. Bäckman L., Jones S., Berger A.K., Laukka E.J., Small B.J. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005, 19:520-531.
30. Sprecher E., Becker Y. Detection of IL-1 beta, TNF-alpha, and IL-6 gene transcription by the polymerase chain reaction in keratinocytes, langerhans cells and peritoneal exudate cells during infection with herpes simplex virus-1. Arch. Virol. 1992, 126:253-269.
31. Rubio-Perez J.M., Morillas-Ruiz J.M. A review: inflammatory process in Alzheimer's disease, role of cytokines. Sci. World J. 2012, 2012:756357.
32. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007, 7:161-167.